How Placebo Surgery Experiments Challenged Orthopedic Medicine

180 Patients, Three Incisions, and No Difference

In 2002, orthopedic surgeon J. Bruce Moseley published a study in the New England Journal of Medicine that shook the foundations of one of the most common surgeries in the world. He randomly assigned 180 patients with osteoarthritis of the knee to one of three groups: arthroscopic debridement (smoothing damaged cartilage), arthroscopic lavage (flushing the joint), or sham surgery (three skin incisions with no instrument entry into the joint). Patients in the sham group received the same anesthesia, the same pre-operative preparation, and heard the same sounds—Moseley splashed saline and used instruments to simulate the procedure. None of the patients knew which group they were in.

At every follow-up point over two years, all three groups reported the same level of pain relief and functional improvement. The sham surgery patients did just as well as those who received the real procedure. Arthroscopic surgery for osteoarthritis of the knee—performed over 650,000 times per year in the United States alone at the time—worked no better than a placebo.

Why Sham Surgery Trials Are So Rare

Drug trials routinely use placebos. Surgical trials almost never do. The reasons are ethical, practical, and cultural.

• Surgery involves anesthesia, incisions, and infection risk—exposing control patients to these harms requires strong justification
• Institutional review boards (ethics committees) are reluctant to approve sham procedures
• Surgeons argue their skills cannot be "blinded" and that each case is unique
• Patient recruitment is difficult—few volunteer for possible fake surgery
• The surgical community has historically resisted placebo-controlled trials, viewing them as unnecessary

As a result, most surgical procedures enter widespread practice based on case series, observational studies, or comparison with non-surgical treatment—not placebo-controlled randomized trials. The Moseley study was one of the first to test a common orthopedic procedure against a true sham, and its results forced an uncomfortable question: how many other surgeries would fail the same test?

The Cascade of Sham Surgery Trials

The Moseley study opened the door. Over the next two decades, researchers applied the same methodology to other common procedures. The results were consistently surprising.

The FIDELITY Trial—Meniscal Tears Under Scrutiny

The 2013 Finnish FIDELITY trial targeted an even more common procedure than the one Moseley studied. Arthroscopic partial meniscectomy—trimming a torn meniscus—is the single most performed orthopedic surgery worldwide, with over 700,000 procedures annually in the United States. The meniscus is the C-shaped cartilage pad that cushions the knee joint. Tears in the meniscus are extremely common in middle-aged and older adults, often found incidentally on MRI scans of patients with knee pain.

The trial randomized 146 patients with degenerative meniscal tears (not acute traumatic injuries) to either partial meniscectomy or sham surgery. Both groups improved substantially. There was no significant difference between them at any follow-up point through 12 months.

• Degenerative meniscal tears are present in ~35% of adults over 50 on MRI, most without symptoms
• The presence of a tear on MRI does not mean the tear is causing the pain
• Post-operative improvement may reflect natural history, regression to the mean, and placebo response
• Subsequent studies confirmed the finding: physical therapy produces equivalent outcomes for most degenerative tears

The Shoulder Decompression Story

Subacromial decompression—shaving bone from the underside of the acromion to create more space for the rotator cuff—was one of the most commonly performed shoulder surgeries. The 2018 CSAW trial (Can Shoulder Arthroscopy Work?) randomized 313 patients to decompression surgery, arthroscopy without decompression (camera insertion only), or no surgery. All three groups improved equally. The bone-shaving procedure that surgeons had performed for decades added nothing beyond the placebo effect of surgery itself.

The implications were staggering. The trial suggested that surgeons were performing a real operation—with real risks including infection, nerve damage, and anesthesia complications—that produced benefits entirely attributable to the ritual of surgery rather than the procedure's mechanical effect.

The Economics of Unnecessary Surgery

The financial scale of potentially unnecessary procedures is enormous.

Practice has changed, but slowly. Arthroscopic debridement for knee osteoarthritis declined substantially after 2002, and clinical guidelines now recommend against it. But partial meniscectomy rates have decreased more slowly—many surgeons argue that the FIDELITY trial excluded the patients most likely to benefit (younger, traumatic tears), and that clinical experience supports the procedure in selected cases.

The Placebo Effect in Surgery—What Drives It

Sham surgery produces real, measurable improvements. Patients report less pain, better function, and higher satisfaction. The mechanisms are not fully understood but likely include:

• Expectation: Patients believe surgery will help; expectation alone activates endogenous pain modulation pathways
• Conditioning: The hospital environment, anesthesia, and post-operative care create conditioned responses associated with healing
• Regression to mean: Patients elect surgery when symptoms are worst; natural fluctuation produces improvement regardless of treatment
• Attention and care: Post-surgical rehabilitation, follow-up visits, and focused attention on recovery contribute to improvement
• Neurobiological: Placebo responses activate opioid and dopamine pathways that genuinely reduce pain perception

The question is not whether the placebo effect is real—it is. The question is whether it is ethical to produce that effect through an invasive procedure when the same benefit could come from a less risky intervention.

This article is for informational purposes only. Consult a qualified professional.